Antibiotic grading management or new opportunities for Chinese medicine

The Antimicrobial Drug Administration, which was originally scheduled to be implemented on July 1st in the "most stringent hospital", has not been settled, and it has already been heated up. It is reported that China has no longer launched a unified version of the hierarchical directory, the development of power will be decentralized to the provincial and municipal health offices. Although the unified version of the hierarchical catalogue is no longer introduced, the country’s policy guidance on strictly monitoring antibiotics is still clear and is being gradually implemented.

Grading management is an international common management method for antibiotics and has achieved good results. Many regions in China have been learning to explore. In recent years, under the combined effects of curbing the effects of antibiotic abuse and the emergence of “super bacteria”, the state has increased its efforts in the management of antibacterial drugs and it has become necessary to adopt a hierarchical management. As a new management idea, the graded management approach will inevitably have an impact on the terminal medication and market landscape. Therefore, although the final document has not yet been fully completed, it has already attracted the attention of the industry.

Some experts believe that the Ministry of Health is focusing on combating the current abuse of antibiotics in the clinic, and it undoubtedly provides an opportunity for the development of heat-clearing, detoxifying Chinese medicine injections with antibacterial and anti-inflammatory effects. Because the Qingrejiedu traditional Chinese medicine injection has many antibacterial and anti-inflammatory effects, it is known as "green antibiotics." After the official implementation of the “Administrative Measures for the Clinical Application of Antimicrobial Agents”, the market for anti-infective drugs will be severely shrunk. This is an excellent opportunity for the market of Qingrejiedu Traditional Chinese Medicine Injection to expand its market. However, in recent years, there have been frequent occurrences of safety incidents in some traditional Chinese medicine injections, and people have paid more attention to the safety of traditional Chinese medicine injections than ever before. Therefore, only traditional Chinese medicine injections with excellent quality, high safety, and effective curative effects can rapidly expand the market.

Shanghai Jian Bao Pharmaceutical Co., Ltd.'s heavy product - Tanreqing injection consists of bear bile powder, astragalus, goat's horn, honeysuckle, forsythia, with antibacterial, anti-inflammatory, anti-virus, antipyretic and other comprehensive effects. , Widely used in pneumonia, bronchitis, upper respiratory tract infections, flu, etc., because of its controllable quality, high safety, and definite curative effect, it is known as a representative of modern Chinese medicine injections, "safety" injection of modern Chinese medicine, in detoxification The market share of traditional Chinese medicine injections has been at the forefront. Therefore, relevant experts predict that after antibiotics are administered in different grades, Tanreqing Injection will likely rapidly expand the market with its good reputation, and Kaibao Pharmaceutical will also make further developments.